nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—NGF—chronic kidney failure	0.0935	0.319	CrCbGaD
Bupranolol—Gemfibrozil—PPARA—chronic kidney failure	0.081	0.277	CrCbGaD
Bupranolol—Gemfibrozil—CYP2C19—chronic kidney failure	0.0263	0.0899	CrCbGaD
Bupranolol—Clenbuterol—TNF—chronic kidney failure	0.0181	0.0619	CrCbGaD
Bupranolol—Timolol—CYP2C19—chronic kidney failure	0.018	0.0616	CrCbGaD
Bupranolol—Gemfibrozil—CYP3A4—chronic kidney failure	0.0167	0.0572	CrCbGaD
Bupranolol—Clenbuterol—CYP1A1—chronic kidney failure	0.0138	0.047	CrCbGaD
Bupranolol—Timolol—ABCB1—chronic kidney failure	0.00955	0.0326	CrCbGaD
Bupranolol—Salbutamol—CYP3A4—chronic kidney failure	0.00817	0.0279	CrCbGaD
Bupranolol—Nadolol—ABCB1—chronic kidney failure	0.00758	0.0259	CrCbGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00231	0.00326	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—EDN1—chronic kidney failure	0.00229	0.00324	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL5—chronic kidney failure	0.00227	0.00321	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—NPY—chronic kidney failure	0.00216	0.00305	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PTH—chronic kidney failure	0.00215	0.00304	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—NPY—chronic kidney failure	0.00211	0.00299	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.0021	0.00297	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CRH—chronic kidney failure	0.00208	0.00295	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—OXT—chronic kidney failure	0.00208	0.00295	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—NPY—chronic kidney failure	0.00206	0.00291	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00205	0.00291	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR5—chronic kidney failure	0.00205	0.00289	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—OXT—chronic kidney failure	0.00204	0.00288	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CRH—chronic kidney failure	0.00204	0.00288	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CRH—chronic kidney failure	0.00198	0.00281	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—OXT—chronic kidney failure	0.00198	0.00281	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—NPS—chronic kidney failure	0.00198	0.00279	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—COL4A5—chronic kidney failure	0.00197	0.00279	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD1—chronic kidney failure	0.00194	0.00274	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—NPS—chronic kidney failure	0.00193	0.00273	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD1—chronic kidney failure	0.0019	0.00268	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—NPS—chronic kidney failure	0.00188	0.00266	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00188	0.00265	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NPY—chronic kidney failure	0.00187	0.00264	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.00186	0.00263	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD1—chronic kidney failure	0.00184	0.00261	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00183	0.00259	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TFDP2—chronic kidney failure	0.00183	0.00259	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.00182	0.00257	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CRH—chronic kidney failure	0.0018	0.00255	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—OXT—chronic kidney failure	0.0018	0.00255	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00179	0.00254	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00178	0.00252	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00177	0.0025	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—F2—chronic kidney failure	0.00176	0.00248	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00175	0.00247	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00173	0.00245	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—NPS—chronic kidney failure	0.00171	0.00242	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD1—chronic kidney failure	0.00168	0.00237	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PGF—chronic kidney failure	0.00163	0.00231	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—POMC—chronic kidney failure	0.0016	0.00226	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00159	0.00225	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL2—chronic kidney failure	0.00156	0.00221	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00156	0.00221	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CRHR1—chronic kidney failure	0.00154	0.00217	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKAG2—chronic kidney failure	0.00154	0.00217	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CRHR1—chronic kidney failure	0.0015	0.00213	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—COL4A3—chronic kidney failure	0.00146	0.00206	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AVP—chronic kidney failure	0.00143	0.00202	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HBEGF—chronic kidney failure	0.00142	0.00201	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PTH—chronic kidney failure	0.00141	0.00199	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AVP—chronic kidney failure	0.0014	0.00198	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CRHR1—chronic kidney failure	0.0014	0.00197	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CRHR1—chronic kidney failure	0.00139	0.00196	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PTH—chronic kidney failure	0.00137	0.00194	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00137	0.00193	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CRHR1—chronic kidney failure	0.00136	0.00193	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AVP—chronic kidney failure	0.00136	0.00192	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—EDN1—chronic kidney failure	0.00136	0.00192	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL5—chronic kidney failure	0.00135	0.00191	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00134	0.00189	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LRP2—chronic kidney failure	0.00133	0.00188	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—EDN1—chronic kidney failure	0.00133	0.00188	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL5—chronic kidney failure	0.00132	0.00186	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—EDN1—chronic kidney failure	0.00129	0.00183	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCL5—chronic kidney failure	0.00128	0.00181	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PTH—chronic kidney failure	0.00128	0.0018	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTH—chronic kidney failure	0.00127	0.0018	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PTH—chronic kidney failure	0.00125	0.00177	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00125	0.00176	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CYBB—chronic kidney failure	0.00124	0.00175	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AVP—chronic kidney failure	0.00123	0.00175	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—NPY—chronic kidney failure	0.00122	0.00173	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00122	0.00172	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00122	0.00172	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR5—chronic kidney failure	0.00121	0.00172	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—NPY—chronic kidney failure	0.00119	0.00169	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00119	0.00169	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR5—chronic kidney failure	0.00119	0.00168	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—OXT—chronic kidney failure	0.00118	0.00167	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CRH—chronic kidney failure	0.00118	0.00167	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EDN1—chronic kidney failure	0.00117	0.00166	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF23—chronic kidney failure	0.00117	0.00166	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—COL4A5—chronic kidney failure	0.00117	0.00165	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL5—chronic kidney failure	0.00117	0.00165	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR5—chronic kidney failure	0.00116	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CRH—chronic kidney failure	0.00115	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—OXT—chronic kidney failure	0.00115	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—COL4A5—chronic kidney failure	0.00114	0.00162	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—NPS—chronic kidney failure	0.00112	0.00158	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NPY—chronic kidney failure	0.00111	0.00157	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NPY—chronic kidney failure	0.0011	0.00156	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD1—chronic kidney failure	0.00109	0.00155	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—NPS—chronic kidney failure	0.00109	0.00154	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TFDP2—chronic kidney failure	0.00109	0.00154	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NPY—chronic kidney failure	0.00108	0.00153	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD1—chronic kidney failure	0.00107	0.00151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—OXT—chronic kidney failure	0.00107	0.00151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CRH—chronic kidney failure	0.00107	0.00151	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CRH—chronic kidney failure	0.00106	0.0015	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—OXT—chronic kidney failure	0.00106	0.0015	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00106	0.0015	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TFDP2—chronic kidney failure	0.00106	0.0015	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR5—chronic kidney failure	0.00105	0.00148	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—OXT—chronic kidney failure	0.00105	0.00148	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CRH—chronic kidney failure	0.00105	0.00148	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—F2—chronic kidney failure	0.00104	0.00147	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00104	0.00147	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NCF1—chronic kidney failure	0.00102	0.00144	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—F2—chronic kidney failure	0.00102	0.00144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—NPS—chronic kidney failure	0.00101	0.00143	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NPS—chronic kidney failure	0.00101	0.00143	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD1—chronic kidney failure	0.000994	0.00141	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—F2—chronic kidney failure	0.000992	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—NPS—chronic kidney failure	0.000992	0.0014	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD1—chronic kidney failure	0.00099	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD1—chronic kidney failure	0.000973	0.00138	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PGF—chronic kidney failure	0.000969	0.00137	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CYBA—chronic kidney failure	0.000958	0.00136	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—POMC—chronic kidney failure	0.000949	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PGF—chronic kidney failure	0.000948	0.00134	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL2—chronic kidney failure	0.000929	0.00131	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—chronic kidney failure	0.000929	0.00131	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKAG2—chronic kidney failure	0.000911	0.00129	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL2—chronic kidney failure	0.000908	0.00128	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—chronic kidney failure	0.000904	0.00128	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—F2—chronic kidney failure	0.000901	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKAG2—chronic kidney failure	0.000892	0.00126	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—COL4A3—chronic kidney failure	0.000864	0.00122	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HBEGF—chronic kidney failure	0.000845	0.0012	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—COL4A3—chronic kidney failure	0.000845	0.0012	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HBEGF—chronic kidney failure	0.000841	0.00119	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HBEGF—chronic kidney failure	0.000827	0.00117	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CRHR1—chronic kidney failure	0.000824	0.00117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—chronic kidney failure	0.000821	0.00116	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AVP—chronic kidney failure	0.000807	0.00114	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CRHR1—chronic kidney failure	0.000806	0.00114	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL2—chronic kidney failure	0.000803	0.00114	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LRP2—chronic kidney failure	0.00079	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AVP—chronic kidney failure	0.00079	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LRP2—chronic kidney failure	0.000773	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDN1—chronic kidney failure	0.000768	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCL5—chronic kidney failure	0.000762	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTH—chronic kidney failure	0.000754	0.00107	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDN1—chronic kidney failure	0.000751	0.00106	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCL5—chronic kidney failure	0.000745	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTH—chronic kidney failure	0.000737	0.00104	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CYBB—chronic kidney failure	0.000735	0.00104	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AVP—chronic kidney failure	0.000733	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AVP—chronic kidney failure	0.00073	0.00103	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CYBB—chronic kidney failure	0.000719	0.00102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AVP—chronic kidney failure	0.000717	0.00101	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDN1—chronic kidney failure	0.000697	0.000986	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF23—chronic kidney failure	0.000696	0.000984	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDN1—chronic kidney failure	0.000694	0.000981	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL5—chronic kidney failure	0.000692	0.000978	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL5—chronic kidney failure	0.000689	0.000974	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR5—chronic kidney failure	0.000686	0.00097	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDN1—chronic kidney failure	0.000682	0.000964	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF23—chronic kidney failure	0.000681	0.000962	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL5—chronic kidney failure	0.000677	0.000957	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LPL—chronic kidney failure	0.000673	0.000952	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR5—chronic kidney failure	0.000671	0.000949	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPY—chronic kidney failure	0.000655	0.000926	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPY—chronic kidney failure	0.000641	0.000906	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NGF—chronic kidney failure	0.000638	0.000902	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OXT—chronic kidney failure	0.000632	0.000893	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CRH—chronic kidney failure	0.000632	0.000893	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR5—chronic kidney failure	0.000623	0.000881	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR5—chronic kidney failure	0.00062	0.000877	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CRH—chronic kidney failure	0.000618	0.000874	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OXT—chronic kidney failure	0.000618	0.000874	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR5—chronic kidney failure	0.00061	0.000862	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NCF1—chronic kidney failure	0.000605	0.000855	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPS—chronic kidney failure	0.000599	0.000847	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NCF1—chronic kidney failure	0.000592	0.000837	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—F2—chronic kidney failure	0.000589	0.000833	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD1—chronic kidney failure	0.000587	0.00083	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPS—chronic kidney failure	0.000586	0.000828	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—F2—chronic kidney failure	0.000576	0.000814	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD1—chronic kidney failure	0.000575	0.000812	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CYBA—chronic kidney failure	0.000569	0.000804	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CYBA—chronic kidney failure	0.000556	0.000787	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—chronic kidney failure	0.000536	0.000758	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—F2—chronic kidney failure	0.000535	0.000756	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—F2—chronic kidney failure	0.000532	0.000752	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—chronic kidney failure	0.000525	0.000742	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—F2—chronic kidney failure	0.000523	0.00074	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IRS1—chronic kidney failure	0.000503	0.000712	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HBEGF—chronic kidney failure	0.000499	0.000706	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HBEGF—chronic kidney failure	0.000489	0.000691	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—chronic kidney failure	0.000487	0.000689	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—chronic kidney failure	0.000485	0.000685	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—chronic kidney failure	0.000477	0.000674	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—chronic kidney failure	0.000476	0.000674	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—chronic kidney failure	0.000474	0.000671	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—chronic kidney failure	0.000466	0.000659	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—chronic kidney failure	0.000466	0.000659	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—chronic kidney failure	0.000443	0.000626	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—KRAS—chronic kidney failure	0.000438	0.00062	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AVP—chronic kidney failure	0.000433	0.000612	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AVP—chronic kidney failure	0.000424	0.000599	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—chronic kidney failure	0.000423	0.000598	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—chronic kidney failure	0.000412	0.000582	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—chronic kidney failure	0.000409	0.000578	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—chronic kidney failure	0.000403	0.00057	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—chronic kidney failure	0.0004	0.000565	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LPL—chronic kidney failure	0.0004	0.000565	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RELA—chronic kidney failure	0.000398	0.000563	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LPL—chronic kidney failure	0.000391	0.000553	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGF—chronic kidney failure	0.000378	0.000535	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGF—chronic kidney failure	0.00037	0.000523	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR5—chronic kidney failure	0.000368	0.000521	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR5—chronic kidney failure	0.00036	0.000509	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—chronic kidney failure	0.000357	0.000504	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKB1—chronic kidney failure	0.000336	0.000475	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2—chronic kidney failure	0.000316	0.000447	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2—chronic kidney failure	0.000309	0.000437	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—chronic kidney failure	0.000305	0.000431	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IRS1—chronic kidney failure	0.000299	0.000422	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IRS1—chronic kidney failure	0.000292	0.000413	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—chronic kidney failure	0.000288	0.000407	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—chronic kidney failure	0.000282	0.000398	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—chronic kidney failure	0.000281	0.000398	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—chronic kidney failure	0.00028	0.000395	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—chronic kidney failure	0.000277	0.000391	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—chronic kidney failure	0.000275	0.000389	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—chronic kidney failure	0.000271	0.000383	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—chronic kidney failure	0.000263	0.000372	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—KRAS—chronic kidney failure	0.00026	0.000368	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KRAS—chronic kidney failure	0.000259	0.000366	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—chronic kidney failure	0.000257	0.000364	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—KRAS—chronic kidney failure	0.000255	0.00036	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—chronic kidney failure	0.000251	0.000355	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—chronic kidney failure	0.000245	0.000347	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RELA—chronic kidney failure	0.000236	0.000334	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RELA—chronic kidney failure	0.000231	0.000327	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—chronic kidney failure	0.000212	0.000299	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—chronic kidney failure	0.000211	0.000298	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—chronic kidney failure	0.000207	0.000293	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKB1—chronic kidney failure	0.000199	0.000282	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKB1—chronic kidney failure	0.000195	0.000276	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—chronic kidney failure	0.000181	0.000256	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—chronic kidney failure	0.000177	0.00025	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—chronic kidney failure	0.000166	0.000235	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—chronic kidney failure	0.000162	0.00023	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KRAS—chronic kidney failure	0.000154	0.000217	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KRAS—chronic kidney failure	0.00015	0.000213	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—chronic kidney failure	0.000125	0.000177	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—chronic kidney failure	0.000122	0.000173	CbGpPWpGaD
